Company Overview of Nuo Therapeutics, Inc.
Nuo Therapeutics, Inc., a biomedical company, provides biodynamic therapies for wound care in the United States and internationally. Its flagship product is Aurix system, a biodynamic hematogel that harnesses a patient's innate regenerative abilities for the management of various wounds. The company also offers Angel Concentrated Platelet Rich Plasma System, a multi-functional cell separation device, which produces concentrated platelet rich plasma for use in the operating room and clinic, as well as in a range of orthopedic and cardiovascular indications; ancillary products, such as phlebotomy and applicator supplies; and activAT, which produces autologous thrombin serum from platelet poor ...
207A Perry Parkway
Gaithersburg, MD 20877
Founded in 1987
Key Executives for Nuo Therapeutics, Inc.
Chief Executive Officer, Chief Financial Officer and Executive Director
Head of Comprehensive Clinical Trial Data Audit
Chief Restructuring Officer
Director of Quality Assurance and Regulatory Affairs
Compensation as of Fiscal Year 2016.
Nuo Therapeutics, Inc. Key Developments
Nuo Therapeutics, Inc. Appoints David E. Jorden as Chief Executive Officer and Chief Financial Officer
Jul 8 16
The Board of Directors of Nuo Therapeutics, Inc. on July 1, 2016 elected David E. Jorden as Chief Executive Officer and Chief Financial Officer of the company. Mr. Jorden had previously served as the company’s Acting Chief Executive Officer and Acting Chief Financial Officer.
Nuo Therapeutics, Inc. Engages CohnReznick LLP as Independent Registered Public Accounting Firm
Jun 16 16
On June 15, 2016, the Audit Committee of the Board of Directors of Nuo Therapeutics, Inc. engaged CohnReznick LLP as the company’s independent registered public accounting firm for the company’s fiscal year ended December 31, 2015.
Stegman & Company Resigns as Independent Registered Public Accounting Firm of Nuo Therapeutics, Inc
Jun 10 16
Nuo Therapeutics, Inc.'s independent registered public accounting firm, Stegman & Company announced that effective June 1, 2016 substantially all directors and employees of Stegman have joined Dixon Hughes Goodman LLP. As a result, effective June 1, 2016 Stegman resigned as the company's independent registered public accounting firm. A successor independent registered public accounting firm has not yet been engaged by the company as of the date of this filing.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 5, 2016
January 26, 2016